Zenas BioPharma, Inc. (ZBIO)
34.97
-1.34
(-3.69%)
USD |
NASDAQ |
Jan 02, 10:35
Zenas BioPharma Shareholders Equity (Quarterly): 196.43M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 79.28B |
| Eli Lilly & Co. | 23.79B |
| Royalty Pharma Plc | 6.414B |
| Nektar Therapeutics | 85.09M |
| Rigel Pharmaceuticals, Inc. | 117.61M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 322.02M |
| Total Liabilities (Quarterly) | 125.59M |
| Debt to Equity Ratio | 0.0041 |
| Current Ratio | 5.659 |
| Net Debt Paydown Yield | -0.01% |